WVE
Wave Life Sciences·NASDAQ
--
--(--)
--
--(--)
4.88 / 10
Netural
Capital flow assessment yields 7.6/10, indicating robust fund inflows, especially at the small-scale level. Analyst coverage is limited but overwhelmingly bullish (Strong Buy/Buy). Together, the positive liquidity and analyst sentiment partially offset the weak fundamentals and technicals, yet not enough to change the defensive rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-05
InstitutionCantor Fitzgerald
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for WVE?
- WVE holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.88/10 (Netural).
